GELS
Gelteq Limited Ordinary Shares
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.90
+0.76%Jun 12, 2026, 16:30 UTC
Gelteq completed veterinary palatability trials with Kemin, validating its Gelteq® technology for animal health applications.
Source:Jun 4, 2026, 13:08 UTC
Gelteq Limited established a new Center of Excellence in Guangdong Province, China, to accelerate product development and commercial expansion.
Source: